Kit media
Agilent Technologies, the world leader in electronic instrumentation and life sciences (with $6.6 billion in sales in 2011), is strengthening its two major activities, with the acquisition of the data transmission test business of the American company Centellax and that of the diagnostic tools for cancer the Danish company Dako. Agilent Technologies has invested $2.2 billion to take control of Dako, which has a turnover of $340 million for a workforce of 1,000 people, mostly located in Denmark.
The acquisition of Dako further reinforces the pre-eminence withinAgilent of the life sciences sector over that of electronic instrumentation...
Find out more: www.home.agilent.com/agilent/home.jspx?cc=FR&lc=fre
